Incremental predictive value of the INFLA-score for stroke-associated pneumonia in patients with acute ischemic stroke: a retrospective cohort study

Stroke-associated pneumonia (SAP) is a frequent and severe complication of acute ischemic stroke (AIS). This study aimed to evaluate the predictive value of the low-grade inflammation score (INFLA-score), a composite inflammatory marker, for the development of SAP in AIS patients. We retrospectively analyzed data from 692 patients with AIS. The INFLA-score was calculated based on the deciles of white blood cell (WBC) count, platelet (PLT) count, neutrophil-to-lymphocyte ratio (NLR), and high-sensitivity C-reactive protein (hs-CRP). Multivariable logistic regression was used to identify independent risk factors for SAP. We compared the predictive performance of the INFLA-score with that of traditional inflammatory markers, including NLR, platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR). Predictive performance was compared using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Clinical utility was assessed using decision curve analysis (DCA). Of the 692 patients, 164 (23.7%) developed SAP. Multivariable analysis showed that a higher INFLA-score was an independent predictor of SAP (OR = 1.180, 95% CI: 1.132–1.233, p < 0.001). The AUC of the INFLA-score (0.777) was significantly higher than those of NLR (0.631), PLR (0.658), and MLR (0.641) (all DeLong p < 0.001), yielding a substantial reclassification gain. Furthermore, incorporating the INFLA-score into the baseline A2DS2 model significantly enhanced the predictive performance, with a significant net reclassification improvement (NRI = 0.163, p < 0.001) and integrated discrimination improvement (IDI = 0.114, p < 0.001). Restricted cubic spline analysis showed a positive association between the INFLA-score and SAP risk, with no evidence of nonlinearity ( p for nonlinearity = 0.428). DCA curves demonstrated high clinical net benefit for the integrated model. The INFLA-score is a robust and independent predictor of SAP in AIS patients. The score showed better discrimination than traditional inflammatory ratios and may improve early SAP risk stratification, pending external validation.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12883-026-05586-x
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Incremental predictive value of the INFLA-score for stroke-associated pneumonia in patients with acute ischemic stroke: a retrospective cohort study

Li Liu, Xinyu Wang, Xinying Liu, Qiang Fu et al.
2 links
BMC Neurology
Inflammatory Biomarkers in Disease Prognosis
article

Incremental predictive value of the INFLA-score for stroke-associated pneumonia in patients with acute ischemic stroke: a retrospective cohort study

Li Liu, Xinyu Wang, Xinying Liu, Qiang Fu, Xiaokun Yang, Shuo Yang
article en

Abstract

Stroke-associated pneumonia (SAP) is a frequent and severe complication of acute ischemic stroke (AIS). This study aimed to evaluate the predictive value of the low-grade inflammation score (INFLA-score), a composite inflammatory marker, for the development of SAP in AIS patients. We retrospectively analyzed data from 692 patients with AIS. The INFLA-score was calculated based on the deciles of white blood cell (WBC) count, platelet (PLT) count, neutrophil-to-lymphocyte ratio (NLR), and high-sensitivity C-reactive protein (hs-CRP). Multivariable logistic regression was used to identify independent risk factors for SAP. We compared the predictive performance of the INFLA-score with that of traditional inflammatory markers, including NLR, platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR). Predictive performance was compared using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Clinical utility was assessed using decision curve analysis (DCA). Of the 692 patients, 164 (23.7%) developed SAP. Multivariable analysis showed that a higher INFLA-score was an independent predictor of SAP (OR = 1.180, 95% CI: 1.132–1.233, p < 0.001). The AUC of the INFLA-score (0.777) was significantly higher than those of NLR (0.631), PLR (0.658), and MLR (0.641) (all DeLong p < 0.001), yielding a substantial reclassification gain. Furthermore, incorporating the INFLA-score into the baseline A2DS2 model significantly enhanced the predictive performance, with a significant net reclassification improvement (NRI = 0.163, p < 0.001) and integrated discrimination improvement (IDI = 0.114, p < 0.001). Restricted cubic spline analysis showed a positive association between the INFLA-score and SAP risk, with no evidence of nonlinearity ( p for nonlinearity = 0.428). DCA curves demonstrated high clinical net benefit for the integrated model. The INFLA-score is a robust and independent predictor of SAP in AIS patients. The score showed better discrimination than traditional inflammatory ratios and may improve early SAP risk stratification, pending external validation.

BMC Neurology
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon